1. Home
  2. RLAY

as 12-20-2024 3:41pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

;SMA (50)$5.42EMA (200)$6.94O: $4.20 H: $4.31 L: $4.20 C: $4.24 +0.04 (+0.95%)Elder Ray −0.22, −0.33
Founded: 2015 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 1.1B IPO Year: 2020
Target Price: $20.11 AVG Volume (30 days): 2.6M
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.61 EPS Growth: N/A
52 Week Low/High: $4.11 - $12.14 Next Earning Date: 11-06-2024
Revenue: $10,006,000 Revenue Growth: -61.22%
Revenue Growth (this year): -59.7% Revenue Growth (next year): -92.88%

RLAY Daily Stock ML Predictions

SELLHOLDBUYas of 8 hours ago

Stock Insider Trading Activity of Relay Therapeutics Inc. (RLAY)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Patel Sanjiv RLAY President and CEO Dec 16 '24 Sell $5.00 100,000 $500,000.00 574,548
Bergstrom Donald A RLAY President, R&D Oct 28 '24 Sell $6.06 2,688 $16,289.28 520,745
Adams Brian RLAY Chief Legal Officer Oct 28 '24 Sell $6.06 1,632 $9,889.92 321,907
Catinazzo Thomas RLAY Chief Financial Officer Oct 28 '24 Sell $6.02 9,102 $54,905.12 306,391
Rahmer Peter RLAY See remarks Oct 28 '24 Sell $6.06 1,621 $9,823.26 390,063
Bergstrom Donald A RLAY President, R&D Sep 27 '24 Sell $7.51 648 $4,866.48 520,745
Adams Brian RLAY Chief Legal Officer Sep 27 '24 Sell $7.51 295 $2,215.45 321,907
Catinazzo Thomas RLAY Chief Financial Officer Sep 27 '24 Sell $7.48 6,457 $48,183.97 306,391
Rahmer Peter RLAY See remarks Sep 27 '24 Sell $7.51 245 $1,839.95 390,063

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use